Skip to main content
PMC home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1993 Jul;39:1612–1621.

Anxiety disorders. Focus on obsessive-compulsive disorder.

L Warneke 1
PMCID: PMC2379558  PMID: 8348022

Abstract

Obsessive-compulsive disorder was once thought to be rare. Recent epidemiologic surveys reveal the lifetime prevalence rate to be as high as 3%. We now have greater understanding of the neurophysiologic and neurochemical basis of this very crippling disorder. Although obsessive-compulsive disorder often starts in adolescence or early adulthood and can last a lifetime, effective treatment enables most patients to lead relatively normal lives.

Full text

PDF
1621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams B. L., Warneke L. B., McEwan A. J., Fraser B. A. Single photon emission computerized tomography in obsessive compulsive disorder: a preliminary study. J Psychiatry Neurosci. 1993 May;18(3):109–112. [PMC free article] [PubMed] [Google Scholar]
  2. Ballantine H. T., Jr, Bouckoms A. J., Thomas E. K., Giriunas I. E. Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry. 1987 Jul;22(7):807–819. doi: 10.1016/0006-3223(87)90080-1. [DOI] [PubMed] [Google Scholar]
  3. Barr L. C., Goodman W. K., Price L. H., McDougle C. J., Charney D. S. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr;53 (Suppl):17–28. [PubMed] [Google Scholar]
  4. Baxter L. R. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry. 1990 Feb;51 (Suppl):22–26. [PubMed] [Google Scholar]
  5. Baxter L. R., Jr, Schwartz J. M., Bergman K. S., Szuba M. P., Guze B. H., Mazziotta J. C., Alazraki A., Selin C. E., Ferng H. K., Munford P. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992 Sep;49(9):681–689. doi: 10.1001/archpsyc.1992.01820090009002. [DOI] [PubMed] [Google Scholar]
  6. Bland R. C., Orn H., Newman S. C. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl. 1988;338:24–32. doi: 10.1111/j.1600-0447.1988.tb08544.x. [DOI] [PubMed] [Google Scholar]
  7. Christenson G. A., Mackenzie T. B., Mitchell J. E. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry. 1991 Mar;148(3):365–370. doi: 10.1176/ajp.148.3.365. [DOI] [PubMed] [Google Scholar]
  8. Flament M. F., Whitaker A., Rapoport J. L., Davies M., Berg C. Z., Kalikow K., Sceery W., Shaffer D. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):764–771. doi: 10.1097/00004583-198811000-00018. [DOI] [PubMed] [Google Scholar]
  9. Goodman W. K., McDougle C. J., Price L. H. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr;53 (Suppl):29–37. [PubMed] [Google Scholar]
  10. Hollander E., DeCaria C. M., Schneier F. R., Schneier H. A., Liebowitz M. R., Klein D. F. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment. J Clin Psychiatry. 1990 Mar;51(3):119–123. [PubMed] [Google Scholar]
  11. Husby G., van de Rijn I., Zabriskie J. B., Abdin Z. H., Williams R. C., Jr Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976 Oct 1;144(4):1094–1110. doi: 10.1084/jem.144.4.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Insel T. R. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry. 1992 Sep;49(9):739–744. doi: 10.1001/archpsyc.1992.01820090067011. [DOI] [PubMed] [Google Scholar]
  13. Jenike M. A. Obsessive-compulsive and related disorders: a hidden epidemic. N Engl J Med. 1989 Aug 24;321(8):539–541. doi: 10.1056/NEJM198908243210811. [DOI] [PubMed] [Google Scholar]
  14. Karno M., Golding J. M., Sorenson S. B., Burnam M. A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988 Dec;45(12):1094–1099. doi: 10.1001/archpsyc.1988.01800360042006. [DOI] [PubMed] [Google Scholar]
  15. Laplane D., Baulac M., Widlöcher D., Dubois B. Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry. 1984 Apr;47(4):377–385. doi: 10.1136/jnnp.47.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Luxenberg J. S., Swedo S. E., Flament M. F., Friedland R. P., Rapoport J., Rapoport S. I. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry. 1988 Sep;145(9):1089–1093. doi: 10.1176/ajp.145.9.1089. [DOI] [PubMed] [Google Scholar]
  17. McDougle C. J., Goodman W. K., Price L. H., Delgado P. L., Krystal J. H., Charney D. S., Heninger G. R. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990 May;147(5):652–654. doi: 10.1176/ajp.147.5.652. [DOI] [PubMed] [Google Scholar]
  18. Mindus, Jenike M. A. Neurosurgical treatment of malignant obsessive compulsive disorder. Psychiatr Clin North Am. 1992 Dec;15(4):921–938. [PubMed] [Google Scholar]
  19. Pato M. T., Zohar-Kadouch R., Zohar J., Murphy D. L. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry. 1988 Dec;145(12):1521–1525. doi: 10.1176/ajp.145.12.1521. [DOI] [PubMed] [Google Scholar]
  20. Pauls D. L., Leckman J. F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med. 1986 Oct 16;315(16):993–997. doi: 10.1056/NEJM198610163151604. [DOI] [PubMed] [Google Scholar]
  21. Pitman R. K., Green R. C., Jenike M. A., Mesulam M. M. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry. 1987 Sep;144(9):1166–1171. doi: 10.1176/ajp.144.9.1166. [DOI] [PubMed] [Google Scholar]
  22. Rapoport J. L., Ryland D. H., Kriete M. Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry. 1992 Jul;49(7):517–521. doi: 10.1001/archpsyc.1992.01820070011002. [DOI] [PubMed] [Google Scholar]
  23. Rapoport J. L., Swedo S. E., Leonard H. L. Childhood obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr;53 (Suppl):11–16. [PubMed] [Google Scholar]
  24. Rapoport J. L. The biology of obsessions and compulsions. Sci Am. 1989 Mar;260(3):82–89. doi: 10.1038/scientificamerican0389-82. [DOI] [PubMed] [Google Scholar]
  25. Rasmussen S. A., Eisen J. L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr;53 (Suppl):4–10. [PubMed] [Google Scholar]
  26. Simeon J. G., Thatte S., Wiggins D. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Psychopharmacol Bull. 1990;26(3):285–290. [PubMed] [Google Scholar]
  27. Stein D. J., Shoulberg N., Helton K., Hollander E. The neuroethological approach to obsessive-compulsive disorder. Compr Psychiatry. 1992 Jul-Aug;33(4):274–281. doi: 10.1016/0010-440x(92)90053-s. [DOI] [PubMed] [Google Scholar]
  28. Swedo S. E., Pietrini P., Leonard H. L., Schapiro M. B., Rettew D. C., Goldberger E. L., Rapoport S. I., Rapoport J. L., Grady C. L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry. 1992 Sep;49(9):690–694. doi: 10.1001/archpsyc.1992.01820090018003. [DOI] [PubMed] [Google Scholar]
  29. Swedo S. E., Rapoport J. L., Cheslow D. L., Leonard H. L., Ayoub E. M., Hosier D. M., Wald E. R. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry. 1989 Feb;146(2):246–249. doi: 10.1176/ajp.146.2.246. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES